In November 2025, Iovance reported that clinical results for IOV-4001, a PD-1 inactivated TIL cell therapy, in previously treated advanced melanoma patients are anticipated in the first quarter of ...
Business.com on MSN
Have conditions improved in the workplace for nonbinary professionals?
Resumes with they/them pronouns get 8% less likely to be considered a good fit, with 72% of nonbinary job-seekers fearing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback